These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1648353)

  • 21. Na+/K+-transporting ATPase as a tool in the synthetic further development of cardioactive steroids.
    Repke KR; Weiland J
    Pharmacol Res Commun; 1988 Jun; 20(6):425-50. PubMed ID: 2843934
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis, cardiotonic activity, and structure-activity relationships of 17 beta-guanylhydrazone derivatives of 5 beta-androstane-3 beta, 14 beta-diol acting on the Na+,K(+)-ATPase receptor.
    Cerri A; Serra F; Ferrari P; Folpini E; Padoani G; Melloni P
    J Med Chem; 1997 Oct; 40(21):3484-8. PubMed ID: 9341924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Derivatives of 3-digitoxigenone amidinohydrazone: synthesis and effect on the digitalis receptor of several species. Part 7: Compounds with positive inotropic activity.
    Heber D; Herzig S; Moosig F; Neujahr H
    Pharmazie; 1995 Oct; 50(10):663-7. PubMed ID: 7501687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart.
    Temma K; Akera T
    J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on cardiac ingredients of plants. X. Preparation of nitrates of tetrahydroproscillaridin and their pharmacological activities].
    Tanase T; Murakami N; Nagatsu A; Nagai S; Sakakibara J; Ando H; Hotta Y; Takeya K; Asano M
    Yakugaku Zasshi; 1992 Nov; 112(11):792-803. PubMed ID: 1336548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The comparative efficacy and differences in the molecular mechanism of the inotropic action of cardiac glycosides and nonglycoside cardiotropic agents on the contractile protein system of the myocardium].
    Karsanov NV; Kipshidze NN; Sukoian GV; Guchua ZI; Tatulashvili DR; Karsanov VN; Iarovaia EV; Magaldadze VA; Turmanauli GS
    Eksp Klin Farmakol; 1996; 59(3):28-33. PubMed ID: 8974579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ryanodine on inotropic and arrhythmogenic actions of cardiotonic steroids.
    Kafiluddi R; Kennedy RH; Seifen E
    Eur J Pharmacol; 1986 Nov; 131(2-3):273-8. PubMed ID: 3816957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypertrophy, a physiological adaptation of the heart to a disease].
    Swynghedauw B; Schwartz K
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1249-51. PubMed ID: 6318679
    [No Abstract]   [Full Text] [Related]  

  • 29. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the inotropic mechanisms of cardiac glycosides in cultured heart cells.
    Smith TW; Kim D; Barry WH
    Basic Res Cardiol; 1984; 79 Suppl():140-6. PubMed ID: 6331373
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial mitogenic effect of erythropoietin through the activation of Na(+)-K(+)-ATPase activity.
    Sterin-Borda L; Wald M; Gutnisky A; Casanova M; Arana R; Borda E
    Acta Physiol Pharmacol Ther Latinoam; 1994; 44(1-2):1-10. PubMed ID: 7640398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial membranes: regulation and function of the sodium pump.
    Akera T; Brody TM
    Annu Rev Physiol; 1982; 44():375-88. PubMed ID: 6280587
    [No Abstract]   [Full Text] [Related]  

  • 34. Subclassification of cardiac glycoside receptors.
    Godfraind T
    Basic Res Cardiol; 1984; 79 Suppl():27-34. PubMed ID: 6331377
    [No Abstract]   [Full Text] [Related]  

  • 35. Structure-activity relationship of cardiac steroids having a doubly linked sugar and related compounds for the inhibition of Na+,K+-adenosine triphosphatase.
    Shimada K; Ishii N; Ohishi K; Ro JS; Nambara T
    J Pharmacobiodyn; 1986 Sep; 9(9):755-9. PubMed ID: 3025406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of derivation on the lipophilicity and inhibitory actions of cardiac glycosides on myocardial Na+-K+-ATPase.
    Dzimiri N; Fricke U; Klaus W
    Br J Pharmacol; 1987 May; 91(1):31-8. PubMed ID: 3036289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Amanitin prevents the positive inotropic effect of cardiac glycosides in-vitro.
    Bazzani C; Arletti R; Bertolini A
    J Pharm Pharmacol; 1983 Aug; 35(8):541-2. PubMed ID: 6137549
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemical synthesis of the cardiotonic steroid glycosides and related natural products.
    Heasley B
    Chemistry; 2012 Mar; 18(11):3092-120. PubMed ID: 22354477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MTD approach to quantitative structure-activity relationships for cardiotonic steroids.
    Bohl M; Simon Z
    Z Naturforsch C Biosci; 1985; 40(11-12):858-62. PubMed ID: 3008458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal variations in drug response and staircase phenomena in atrial muscle from a hibernating rodent (Spermophilus richardsonii).
    Charnock JS; Dryden WF; Marshall RJ
    Br J Pharmacol; 1983 Jan; 78(1):151-8. PubMed ID: 6297645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.